Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
03 Oct 2023
Historique:
pubmed: 24 10 2023
medline: 24 10 2023
entrez: 24 10 2023
Statut: epublish

Résumé

Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997-2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection dynamics, presumably via heterosubtypic cross-immunity.

Identifiants

pubmed: 37873362
doi: 10.1101/2023.10.02.23296453
pmc: PMC10593063
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : F31 AI140714
Pays : United States
Organisme : Arthritis Research UK
ID : FC001030
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R35 GM119774
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127893
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93021C00014
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : 75N93019C00051
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI165821
Pays : United States

Références

Elife. 2014 Nov 11;3:
pubmed: 25385532
Euro Surveill. 2015 Feb 26;20(8):
pubmed: 25742433
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
Elife. 2015 Aug 07;4:
pubmed: 26252514
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2752-2757
pubmed: 29483256
PLoS Biol. 2010 Feb 23;8(2):e1000316
pubmed: 20186267
Nature. 2003 Mar 27;422(6930):428-33
pubmed: 12660783
Sci Rep. 2018 Jul 11;8(1):10432
pubmed: 29992986
J Infect Dis. 2009 Jan 15;199(2):168-79
pubmed: 19086914
Am J Prev Med. 2019 Oct;57(4):458-469
pubmed: 31473066
Nat Commun. 2019 Apr 10;10(1):1660
pubmed: 30971703
J Infect Dis. 2012 Jun 15;205(12):1858-68
pubmed: 22492921
Can Commun Dis Rep. 2005 Sep 15;31(18):181-91
pubmed: 16669132
J Infect Dis. 1985 Jan;151(1):81-8
pubmed: 3965596
Epidemiology. 2012 Nov;23(6):829-38
pubmed: 22992574
Elife. 2018 Feb 27;7:
pubmed: 29485041
Sci Transl Med. 2013 Aug 14;5(198):198ra107
pubmed: 23946196
Br Med J. 1971 Aug 26;3(5773):531
pubmed: 5570648
MMWR Morb Mortal Wkly Rep. 2004 Aug 13;53(31):707-10
pubmed: 15306754
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
PLoS Pathog. 2018 Jan 11;14(1):e1006780
pubmed: 29324895
Am J Epidemiol. 2013 Nov 1;178(9):1478-87
pubmed: 24008912
Euro Surveill. 2017 Nov;22(44):
pubmed: 29113630
J Virol. 2013 Oct;87(20):11168-72
pubmed: 23926344
Sci Rep. 2015 Oct 16;5:15279
pubmed: 26472175
PLoS Comput Biol. 2019 Feb 27;15(2):e1006742
pubmed: 30811396
Theor Popul Biol. 2004 Mar;65(2):179-91
pubmed: 14766191
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553
pubmed: 33168723
Microbes Infect. 2008 Jul;10(9):1024-9
pubmed: 18662798
Clin Infect Dis. 2012 Aug;55(3):332-42
pubmed: 22539661
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Science. 2006 Apr 21;312(5772):447-51
pubmed: 16574822
Nature. 1982 Mar 11;296(5853):115-21
pubmed: 6174870
Proc Natl Acad Sci U S A. 1990 Jan;87(2):786-90
pubmed: 2300562
Elife. 2019 Aug 27;8:
pubmed: 31452511
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296675
PLoS Pathog. 2010 May 27;6(5):e1000918
pubmed: 20523898
PLoS Comput Biol. 2010 Aug 12;6(8):
pubmed: 20711361
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6283-8
pubmed: 17395716
Elife. 2013 May 14;2:e00631
pubmed: 23682315
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Clin Infect Dis. 2012 Oct;55(7):951-9
pubmed: 22843783
J Infect Dis. 2021 Nov 16;224(9):1500-1508
pubmed: 34551108
Lancet Glob Health. 2022 Nov;10(11):e1612-e1622
pubmed: 36240828
BMC Bioinformatics. 2020 Jul 14;21(1):307
pubmed: 32664864
Virol J. 2013 Jul 26;10:244
pubmed: 23886073
Nat Rev Genet. 2007 Mar;8(3):196-205
pubmed: 17262054
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Am J Epidemiol. 2012 Oct 1;176(7):649-55
pubmed: 22962250
Clin Infect Dis. 2010 Dec 15;51(12):1370-9
pubmed: 21067351
JAMA Netw Open. 2022 Feb 01;5(2):e220527
pubmed: 35226079
Science. 2006 Dec 22;314(5807):1898-903
pubmed: 17185596
PLoS Pathog. 2019 Dec 19;15(12):e1008109
pubmed: 31856206
Science. 2004 Jul 16;305(5682):371-6
pubmed: 15218094
J Infect Dis. 2015 Oct 15;212(8):1191-9
pubmed: 25858957
Vaccine. 2003 May 1;21(16):1776-9
pubmed: 12686093
Vaccine. 2017 May 15;35(21):2831-2839
pubmed: 28412077
Nat Rev Microbiol. 2018 Jan;16(1):47-60
pubmed: 29081496
J Open Source Softw. 2021;6(57):
pubmed: 34189396
Vaccine. 2009 Apr 21;27(18):2447-52
pubmed: 19368786
Vaccine. 1993;11(10):1037-9
pubmed: 8212824
Euro Surveill. 2017 Feb 9;22(6):
pubmed: 28205503
Elife. 2020 Sep 02;9:
pubmed: 32876050
Nature. 2014 Mar 6;507(7490):57-61
pubmed: 24572367
Science. 2013 Nov 22;342(6161):976-9
pubmed: 24264991
Nature. 1981 Jan 29;289(5796):373-8
pubmed: 6162101
J Virol. 1968 Aug;2(8):778-86
pubmed: 5701819
JAMA. 2000 Oct 4;284(13):1655-63
pubmed: 11015795
BMC Bioinformatics. 2008 Jul 11;9:307
pubmed: 18620558
J Immunol. 2019 Jan 15;202(2):335-340
pubmed: 30617114
J Infect Dis. 1976 Oct;134(4):384-94
pubmed: 789791
Biol Direct. 2006 Oct 26;1:34
pubmed: 17067369
Proc Natl Acad Sci U S A. 1969 Jun;63(2):326-33
pubmed: 5257124
N Engl J Med. 1972 Jun 22;286(25):1329-32
pubmed: 5027388
Science. 2018 Oct 5;362(6410):75-79
pubmed: 30287659
mBio. 2018 Apr 3;9(2):
pubmed: 29615508
Science. 1999 Dec 3;286(5446):1921-5
pubmed: 10583948
MMWR Morb Mortal Wkly Rep. 2021 Jul 23;70(29):1013-1019
pubmed: 34292924
PLoS Comput Biol. 2020 Jun 15;16(6):e1007989
pubmed: 32542015
Influenza Other Respir Viruses. 2018 May;12(3):336-343
pubmed: 29350791
Elife. 2014;3:e01914
pubmed: 24497547
PLoS Comput Biol. 2017 Oct 19;13(10):e1005749
pubmed: 29049288
Emerg Infect Dis. 2004 Jan;10(1):32-9
pubmed: 15078594
J Infect Dis. 2014 Aug 15;210(4):535-44
pubmed: 24731959
J Infect Dis. 2022 Apr 19;225(8):1387-1398
pubmed: 32215564
Science. 2009 Jul 10;325(5937):197-201
pubmed: 19465683
Clin Infect Dis. 2019 May 17;68(11):1798-1806
pubmed: 30204854
Nature. 2001 Dec 13;414(6865):716-23
pubmed: 11742391
Euro Surveill. 2013 Jan 31;18(5):
pubmed: 23399425
Gene. 2008 Dec 31;427(1-2):111-6
pubmed: 18848975
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Vaccine. 2007 Apr 12;25(15):2842-51
pubmed: 17081662
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9538-42
pubmed: 24979763
BMC Biol. 2012 Apr 30;10:38
pubmed: 22546494
PLoS Med. 2009 Nov;6(11):e1000168
pubmed: 19918363
J Infect Dis. 2015 Dec 1;212(11):1701-10
pubmed: 25943206
mBio. 2016 Jan 19;7(1):e01996-15
pubmed: 26787832
Vaccine. 1999 Jul 30;17 Suppl 1:S3-10
pubmed: 10471173
J Infect Dis. 1974 Apr;129(4):411-20
pubmed: 4593871
J Infect Dis. 2013 Mar 15;207(6):974-81
pubmed: 23307936
J Infect Dis. 2016 Oct 1;214(7):1010-9
pubmed: 27190176
Epidemiology. 2009 May;20(3):344-7
pubmed: 19279492
PLoS Genet. 2011 Feb;7(2):e1001301
pubmed: 21390205
Curr Opin Immunol. 2018 Aug;53:38-44
pubmed: 29674167
J Infect Dis. 2017 Apr 1;215(7):1059-1099
pubmed: 28180277
Biostatistics. 2006 Jul;7(3):355-73
pubmed: 16344280
Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1861-70
pubmed: 11779385
Cell. 2018 Apr 5;173(2):417-429.e10
pubmed: 29625056
Vaccine. 2005 Jan 19;23(9):1144-8
pubmed: 15629357
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583
pubmed: 29109276
Infect Control Hosp Epidemiol. 2003 Nov;24(11):839-44
pubmed: 14649772
Nat Commun. 2020 Jun 2;11(1):2741
pubmed: 32488106
Sci Rep. 2022 May 25;12(1):8883
pubmed: 35614123
Annu Rev Immunol. 1990;8:737-71
pubmed: 2188678
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Clin Infect Dis. 2014 Feb;58(3):319-27
pubmed: 24235265
BMC Bioinformatics. 2007 Jan 25;8:25
pubmed: 17254353
mBio. 2016 Apr 19;7(2):e00417-16
pubmed: 27094330
Virology. 2005 Sep 1;339(2):273-80
pubmed: 15996702
Clin Infect Dis. 2019 Nov 13;69(11):1845-1853
pubmed: 30715278
Nat Commun. 2022 Mar 4;13(1):1190
pubmed: 35246548
PLoS Comput Biol. 2017 Feb 10;13(2):e1005382
pubmed: 28187123
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3243-8
pubmed: 19204283
Elife. 2015 Sep 15;4:e07361
pubmed: 26371556
Clin Infect Dis. 2014 Nov 15;59(10):1375-85
pubmed: 25270645
Nature. 2015 Jul 9;523(7559):217-20
pubmed: 26053121
Med J Aust. 1977 Dec 3;2(23):761-5
pubmed: 611373
Epidemics. 2009 Jun;1(2):129-37
pubmed: 21352760
Int J Environ Res Public Health. 2021 May 17;18(10):
pubmed: 34067932
Microbiol Rev. 1992 Mar;56(1):152-79
pubmed: 1579108
J Infect Dis. 2012 Sep 1;206(5):625-7
pubmed: 22723644
Influenza Other Respir Viruses. 2018 Sep;12(5):567-581
pubmed: 29659149
PLoS One. 2014 Mar 25;9(3):e92153
pubmed: 24667168
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
Curr Opin Virol. 2014 Oct;8:85-9
pubmed: 25108824
J Virol. 2013 Apr;87(8):4728-37
pubmed: 23408625
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20748-53
pubmed: 22143798
Virology. 1980 Jul 15;104(1):139-48
pubmed: 6156537
J Stat Softw. 2017;76:
pubmed: 36568334
Vaccine. 2011 Sep 2;29(38):6558-63
pubmed: 21767593
Mol Biol Evol. 2011 Sep;28(9):2443-51
pubmed: 21415025
J Infect Dis. 2020 Jan 1;221(1):8-15
pubmed: 31665373
J Infect Dis. 2006 Jan 1;193(1):49-53
pubmed: 16323131
Sci Transl Med. 2017 Oct 25;9(413):
pubmed: 29070700
J Infect Dis. 2014 Jul 1;210(1):126-37
pubmed: 24446529
Nat Rev Immunol. 2019 Jun;19(6):383-397
pubmed: 30837674
Clin Infect Dis. 2016 Dec 15;63(12):1564-1573
pubmed: 27702768
MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52
pubmed: 19644442
Clin Infect Dis. 2016 Jul 1;63(1):21-32
pubmed: 27025838
BMC Evol Biol. 2011 Jul 25;11:220
pubmed: 21787390
Vaccine. 2003 Nov 7;21(31):4507-13
pubmed: 14575760
mBio. 2015 Mar 10;6(2):e02556
pubmed: 25759506
Vaccine. 2016 Mar 8;34(11):1350-7
pubmed: 26854911
Curr Opin Virol. 2017 Feb;22:105-111
pubmed: 28088686
Clin Infect Dis. 2014 Aug 15;59(4):517-24
pubmed: 24825868
J Exp Med. 2013 Jul 29;210(8):1493-500
pubmed: 23857983
PLoS Curr. 2010 Dec 03;2:RRN1200
pubmed: 21152078
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1701-9
pubmed: 26951657
N Engl J Med. 2017 Aug 10;377(6):534-543
pubmed: 28792867
J Clin Microbiol. 1993 Apr;31(4):836-8
pubmed: 8463393
Cell Host Microbe. 2019 Mar 13;25(3):357-366.e6
pubmed: 30795982
PLoS Med. 2010 Apr 06;7(4):e1000258
pubmed: 20386731
J Virol. 1998 Jul;72(7):5648-53
pubmed: 9621023
Nat Commun. 2021 Jan 11;12(1):222
pubmed: 33431854
PLoS Comput Biol. 2018 Mar 7;14(3):e1006020
pubmed: 29513661
Sci Rep. 2015 Jun 05;5:11013
pubmed: 26046930
Am J Epidemiol. 2006 Feb 15;163(4):316-26
pubmed: 16394205
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Nat Commun. 2021 Feb 12;12(1):1001
pubmed: 33579926
J Infect Dis. 2016 May 15;213(10):1546-56
pubmed: 26743842
Bioinformatics. 2010 May 15;26(10):1340-7
pubmed: 20385727
Am J Transplant. 2020 Dec;20(12):3681-3685
pubmed: 33264506
PLoS Med. 2011 Jul;8(7):e1001051
pubmed: 21750666
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959

Auteurs

Amanda C Perofsky (AC)

Fogarty International Center, National Institutes of Health, United States.
Brotman Baty Institute for Precision Medicine, University of Washington, United States.

John Huddleston (J)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, United States.

Chelsea Hansen (C)

Fogarty International Center, National Institutes of Health, United States.
Brotman Baty Institute for Precision Medicine, University of Washington, United States.

John R Barnes (JR)

Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.

Thomas Rowe (T)

Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.

Xiyan Xu (X)

Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.

Rebecca Kondor (R)

Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.

David E Wentworth (DE)

Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.

Nicola Lewis (N)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

Lynne Whittaker (L)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

Burcu Ermetal (B)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

Ruth Harvey (R)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

Monica Galiano (M)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

Rodney Stuart Daniels (RS)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

John W McCauley (JW)

WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.

Seiichiro Fujisaki (S)

Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.

Kazuya Nakamura (K)

Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.

Noriko Kishida (N)

Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.

Shinji Watanabe (S)

Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.

Hideki Hasegawa (H)

Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.

Sheena G Sullivan (SG)

WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia.

Ian G Barr (IG)

WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia.

Kanta Subbarao (K)

WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia.

Florian Krammer (F)

Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, United States.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, United States.

Trevor Bedford (T)

Brotman Baty Institute for Precision Medicine, University of Washington, United States.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, United States.
Department of Genome Sciences, University of Washington, United States.
Howard Hughes Medical Institute, Seattle, United States.

Cécile Viboud (C)

Fogarty International Center, National Institutes of Health, United States.

Classifications MeSH